RecruitingNot ApplicableNCT07119658

Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial


Sponsor

Indiana University

Enrollment

20 participants

Start Date

Jul 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility. Participants (n=20) will be randomized to intervention or control (usual care). The composite intervention will include an educational video outlining the adverse effects of MetS and the benefit of walking, a written exercise prescription with a defined goal of walking 150 minutes per week, a Fitbit accelerometer device, resources for healthy eating practices, periodic text message reminders, and an urgent referral to primary care and our health system's Healthy Me clinic for follow-up visit. Investigators hypothesize that this approach will change patient understanding and motivation to increase physical activity and healthy eating habits.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Ambulatory adults (18 years of age) presenting to the emergency department setting
  • BMI 30 kg/m2
  • Prior diagnosis of at least one additional comorbid component of metabolic syndrome: hypertension, hyperglycemia, dyslipidemia
  • Clinical plan for discharge

Exclusion Criteria6

  • Age \<18 years
  • Pregnant patients
  • Unable to safely ambulate (including patient or family perception of inability to safely ambulate)
  • Lack of access to smart phone
  • Unable or unwilling to wear Fitbit accelerometer device
  • Unable to obtain informed consent

Interventions

BEHAVIORALComposite intervention to address MetS

The composite intervention includes six components: 1. All patients will be provided a Fitbit Charge device at ED discharge with instructions to wear on their wrist for study duration. 2. Participants in the intervention group will first watch a brief (\~5 minute) educational video outlining the adverse effects of MetS and the benefit of walking, via iPad tablet. 3. Participants in the intervention group will also be given accompanying written "exercise prescription" encouraging them to walk 150 minutes per week. 4. Reminder texts encouraging continued walking behavior (i.e. "Remember to get in your steps!") will be sent to the intervention group, at approximate 2-3x/week intervals for the 3-month follow-up period. 5. The intervention group will also be provided written resources for healthy eating practices upon ED discharge. 6. All intervention group participants will receive referrals into primary care clinic and the Eskenazi Health "Healthy Me" Program for follow-up.


Locations(1)

Sidney & Lois Eskenazi Hospital

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07119658


Related Trials